Austria's diagnostic reagents and other pharmaceutical preparations market has shown consistent growth from 2013 to 2023. The market experienced a compound annual growth rate (CAGR) of 4.28% over the last five years, with a slight dip in 2022 and a subsequent recovery in 2023, reaching 29.89 million Euros, indicating resilience.

Key Variations:

2013-2014: 19.16% increase.
2014-2015: 1.53% increase.
2015-2016: 6.65% increase.
2016-2017: 5.61% increase.
2017-2018: 5.21% increase.
2018-2019: 4.85% increase.
2019-2020: 9.76% increase.
2020-2021: 9.21% increase.
2021-2022: -5.46% decrease.
2022-2023: 3.76% increase.

The five-year forecast from 2024 to 2028 estimates a CAGR of 2.43%, with the market expected to reach 35.133 million Euros by 2028, indicative of a stable yet slower growth compared to the past.

Future Trends to Watch For:

Advances in biotechnology and personalized medicine potentially driving demand.
Regulatory changes and global supply chain adaptations influencing market conditions.
Increased investment in R&D leading to innovative diagnostic solutions.